524238 GUJINJEC

Gujarat Inject (Kerala) Share Price

 

 

Start SIP in GUJINJEC

Start SIP

Performance

  • Low
  • ₹61
  • High
  • ₹61
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹61
  • Open Price₹61
  • Previous Close₹60
  • Volume30,753
  • 50 DMA₹44.79
  • 100 DMA₹37.46
  • 200 DMA₹31.07

Investment Returns

  • Over 1 Month + 52.88%
  • Over 3 Month + 130.19%
  • Over 6 Month + 191.73%
  • Over 1 Year + 131.59%

Smart Investing Starts Here Start SIP with Gujarat Inject (Kerala) for Steady Growth!

Invest Now

Gujarat Inject (Kerala) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 354.3
  • PEG Ratio
  • -4.8
  • Market Cap Cr
  • 89
  • P/B Ratio
  • 8.8
  • Average True Range
  • 1.34
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.88
  • RSI
  • 97.55
  • MFI
  • 92.55

Gujarat Inject (Kerala) Financials

Gujarat Inject (Kerala) Technicals

EMA & SMA

Current Price
₹61.00
+ 0.97 (1.62%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹53.17
  • 50 Day
  • ₹44.79
  • 100 Day
  • ₹37.46
  • 200 Day
  • ₹31.07

Resistance and Support

61.08 Pivot Speed
  • R3 61.38
  • R2 61.31
  • R1 61.15
  • S1 60.92
  • S2 60.85
  • S3 60.69

Gujarat Inject (Kerala) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-20 Audited Results
2025-02-18 Stock Split

Gujarat Inject (Kerala) F&O

Gujarat Inject (Kerala) Shareholding Pattern

0%
90.02%
9.98%

Gujarat Inject (Kerala) FAQs

Gujarat Inject (Kerala) share price is ₹61 As on 20 February, 2026 | 04:43

The Market Cap of Gujarat Inject (Kerala) is ₹89.4 Cr As on 20 February, 2026 | 04:43

The P/E ratio of Gujarat Inject (Kerala) is 354.3 As on 20 February, 2026 | 04:43

The PB ratio of Gujarat Inject (Kerala) is 8.8 As on 20 February, 2026 | 04:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23